1. Home
  2. RPRX vs MAS Comparison

RPRX vs MAS Comparison

Compare RPRX & MAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • MAS
  • Stock Information
  • Founded
  • RPRX 1996
  • MAS 1929
  • Country
  • RPRX United States
  • MAS United States
  • Employees
  • RPRX N/A
  • MAS N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • MAS Industrial Specialties
  • Sector
  • RPRX Health Care
  • MAS Industrials
  • Exchange
  • RPRX Nasdaq
  • MAS Nasdaq
  • Market Cap
  • RPRX 13.9B
  • MAS 12.9B
  • IPO Year
  • RPRX 2020
  • MAS N/A
  • Fundamental
  • Price
  • RPRX $36.46
  • MAS $66.40
  • Analyst Decision
  • RPRX Strong Buy
  • MAS Buy
  • Analyst Count
  • RPRX 3
  • MAS 13
  • Target Price
  • RPRX $47.33
  • MAS $72.65
  • AVG Volume (30 Days)
  • RPRX 4.4M
  • MAS 2.3M
  • Earning Date
  • RPRX 08-07-2025
  • MAS 07-31-2025
  • Dividend Yield
  • RPRX 2.42%
  • MAS 1.87%
  • EPS Growth
  • RPRX 37.60
  • MAS N/A
  • EPS
  • RPRX 2.45
  • MAS 3.66
  • Revenue
  • RPRX $2,263,845,000.00
  • MAS $7,703,000,000.00
  • Revenue This Year
  • RPRX $29.35
  • MAS N/A
  • Revenue Next Year
  • RPRX $7.58
  • MAS $4.05
  • P/E Ratio
  • RPRX $14.83
  • MAS $18.13
  • Revenue Growth
  • RPRX 1.13
  • MAS N/A
  • 52 Week Low
  • RPRX $24.05
  • MAS $56.55
  • 52 Week High
  • RPRX $36.43
  • MAS $86.70
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 64.64
  • MAS 60.01
  • Support Level
  • RPRX $35.01
  • MAS $63.69
  • Resistance Level
  • RPRX $36.33
  • MAS $68.54
  • Average True Range (ATR)
  • RPRX 0.63
  • MAS 1.45
  • MACD
  • RPRX 0.05
  • MAS 0.52
  • Stochastic Oscillator
  • RPRX 90.72
  • MAS 72.55

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About MAS Masco Corporation

Masco manufactures a variety of home improvement and building products. The company's $5-billion plumbing segment, led by the Delta and Hansgrohe brands, sells faucets, showerheads, and other related plumbing fixtures and components. The $3-billion decorative architectural segment primarily sells paints and other coatings under the Behr and Kilz brands, but it also sells builder hardware and lighting products.

Share on Social Networks: